Diagenics產(chǎn)品介紹

更新時間：2019-07-28

點擊次數(shù)：2633

Diagenics成立于1994年，憑借其在過敏診斷和治療領域多年的經(jīng)驗以及用于研究和常規(guī)實驗室的ELISA試劑盒的供應和技術支持而建立了自己的名字。

Diagenics產(chǎn)品介紹

ELISA試劑盒和抗體

Diagenics的團隊都具有研究或體外診斷行業(yè)的背景。自成立以來，我們代表瑞典公司Mercodia在英國。我們的產(chǎn)品組合現(xiàn)已擴展到包括來自眾多精選ELISA試劑盒，抗體和相關產(chǎn)品的精選供應商的產(chǎn)品，以便我們可以為生命科學研究的幾乎所有領域的客戶提供支持。

Mercodia成立于1991年，開發(fā)，生產(chǎn)和銷售基于ELISA技術的診斷試劑盒，用于臨床和研究應用。

Mercodia ELISA試劑盒

如需訂購Mercodia產(chǎn)品，請聯(lián)系。

Mercodia成立于1991年，開發(fā)，生產(chǎn)和銷售基于ELISA技術的診斷試劑盒，用于臨床和研究應用。

臨床和研究領域
糖尿病胰島素是負責控制葡萄糖代謝的主要激素。胰島素的分泌主要受血漿葡萄糖濃度的控制，并且激素具有許多重要的代謝作用。在胰島素依賴性糖尿病（1型糖尿病）和一些其他病癥如低垂體癥中胰島素濃度嚴重降低。胰島素濃度在非胰島素依賴型糖尿病（2型糖尿病），胰島素瘤和某些類型的內(nèi)分泌功能障礙（如庫欣綜合征和肢端肥大癥）中升高。	心血管疾病氧化低密度脂蛋白（LDL）是一種致動脈粥樣硬化斑塊特異性蛋白，直接參與動脈粥樣硬化病變的發(fā)生和發(fā)展。血管造影證實的冠狀動脈疾病患者的血漿氧化LDL水平顯著升高，現(xiàn)在越來越清楚氧化LDL的循環(huán)水平是冠狀動脈粥樣硬化的標志物。載脂蛋白（a）也被研究作為動脈粥樣硬化的獨立危險因素。 ELISA分析可用于兩種分析物。

分析原則

ELISA序列測定和ELISA同時測定原理。

哺乳動物糖尿病

通過使用大鼠或小鼠胰島素ELISA與人胰島素ELISA（0.7％大鼠/小鼠交叉反應）的組合，可以在相同樣品中與人胰島素分開測定大鼠或小鼠胰島素濃度。大鼠胰島素ELISA，豬胰島素ELISA，牛胰島素ELISA，牛胰島素ELISA，小鼠胰島素ELISA，犬胰島素ELISA，馬胰島素ELISA和大鼠Glicentin

人類糖尿病

確定血清或細胞培養(yǎng)基中的胰島素，胰島素原和C-肽是尋找I型和2型糖尿病有效治療方法的有價值的工具。胰島素ELISAs，C肽ELISAs，Leptin ELISA，載脂蛋白ELISA，胰高血糖素ELISA，Glicentin ELISA，GLP-1 NL-ELISA和Lispro NL-ELISA

心血管

Mercodia提供心血管疾病檢測，重點關注動脈粥樣硬化過程的不同機制。

使用說明

PDF包含各種Mercodia產(chǎn)品使用說明的文件。

Mercodia部分產(chǎn)品列表

Description	Rat Insulin ELISA	Ultrasensitive Rat Insulin ELISA	High Range Rat Insulin ELISA
Code No.	10-1250-01 10-1250-10	10-1251-01	10-1145-01
No. of tests	96/10x96	96	96
Measured antigen	Rat/mouse insulin	Rat/mouse insulin	Rat/mouse insulin
Standards ug/l	0, 0.15, 0.4, 1, 3, 5.5	0, 0.02, 0.05, 0.15 0.4, 1.0	0, 3.0, 7.5, 30.0, 75.0, 150.0
Calibration
Incubations (mins)	120+15	120+15	120+15
Sample/sample volume	serum/plasma 10ul	serum/plasma 25ul	serum/plasma 10ul
Sensitivity	≤0.15ug/l	1) ≤0.02ug/l	1.5 ug/l/ 263 pmol/l
Precision intra/inter cv%	<5.2%, <10.1%	1) <3% 1) <5%	<5%/<5%
Hook	>450 ug/l	450 ug/l	576 ug/l 100.8nmol/l
Cross-reactions	Human insulin 167% Insulin Lispro (Humalog®) 167% Human proinsulin 75% Human C-peptide <0.05% IGF-I <0.02% IGF-II <0.02% Rat C-peptide <0.001% Rat proinsulin 7% Mouse insulin 75% Porcine insulin 476% Sheep insulin 179% Bovine insulin 78% No interference by lipaemic, icteric or haemolysed samples	insulin (mouse) 81% insulin (human) 120% insulin (Humalog®)120% proinsulin (human) 71% C-peptide (human) <0.05% No interference by lipaemic, icteric or haemolysed samples	insulin (mouse) 81% insulin (human) 120% insulin (Humalog®) 120 proinsulin (human) 71% C-peptide (human)<0.05% No interference by lipaemic, icteric or haemolysed samples

Description	Porcine Insulin ELISA	Ovine Insulin ELISA	Bovine Insulin ELISA
Code No.	10-1200-01	10-1202-01	10-1201-01
No. of tests	96	96	96
Measured antigen	Porcine insulin	Ovine insulin	Bovine insulin
Standards ug/l	0, 0.02, 0.05, 0.15, 0.5, 1.5	0, 0.05, 0.15, 0.5, 1.5, 3.0	0, 0.05, 0.15, 0.5, 1.5, 3.0
Calibration	in-house reference	in-house reference	in-house reference
Incubations (mins)	120+15	120+15	120+15
Sample/sample volume	Serum/plasma 25ul	Serum/plasma 25ul	Serum/plasma 25ul
Sensitivity	≤0.01ug/l	≤0.025ug/l	≤0.025ug/l
Precision intra/inter cv%	<3.8% <3.9%	<3.7% <6.5%	<5.3% <7.0%
Hook	>1000ug/l	>1000ug/l	>1000ug/l
Cross-reactions	No interference by lipaemic, icteric or haemolysed samples	No interference by lipaemic, icteric or haemolysed samples	No interference by lipaemic, icteric or haemolysed samples

Description	Mouse Insulin ELISA	Ultrasensitive Mouse Insulin ELISA	Glucagon 10ul ELISA
Code No.	10-1247-01 10-1247-10	10-1249-01	10-1281-01
No. of tests	96/10x96	96	96
Measured antigen	Mouse Insulin	Mouse Insulin	Glucagon. validated for rat, mice, porcine & non-human primate.
Standards ug/l	0, 0.188, 0.5, 1.25, 3.75, 6.9	0, 0.025, 0.063, 0.188, 0.5, 1.25
Incubation (mins)	120 + 15	120 + 15	overnight+15
Sample/sample volume	serum/plasma 10ul	serum/plasma 25ul	Serum/plasma/cell culture
Sensitivity	≤0.2 ug/l	≤0.025 ug/l	1.5 pmol/l
Precision intra/inter cv%	<3.2%/<6%	<3%/<5%	Total 8.3 17.9%
Hook	>450 ug/l	>450 ug/l	>8 umol/l
Cross-reactions	No interference by lipaemic, icteric or haemolysed samples	No interference by lipaemic, icteric or haemolysed samples	Oxyntomodulin, human, rat, mouse 2.0% Oxyntomodulin, bovine, canine, porcine n.d. Mini-Glucagon n.d. GLP-1 n.d. GLP-2 n.d. Glicentin, human 1.0% Glicentin, mouse 7.0% Glicentin, rat 4.0%

Description	Rat C-peptide ELISA	Rat/Mouse proinsulin ELISA
Code No.	10-1172-01	10-1232-01
No. of tests	96	96
Measured antigen	Rat C-peptide	Rat and Mouse proinsulin
Standards pmol/l	c. 0 - 4000 (0 + 5 standards)	c. 0 - 2000 (0 + 5 standards)
Incubation (mins)	60 + 60 + 15	120+30
Sample/sample volume	serum/plasma 10ul	serum/plasma 25ul
Sensitivity	%td 3 pmol/l
Precision intra/inter cv%	<4.3%/<7.3%	<3.7%/<6.4%
Hook	400000pmol/l	90000pmol/l
Cross-reactions	Human C-peptide <0.001% Rat proinsulin 4.55% Rat insulin <0.01% No interference by lipaemic, icteric or haemolysed samples	Human insulin <0.0000001% Human proinsulin 2 - 10% (mean 5%) Human C-peptide <0.000001% Rat C-peptide <0.0000001% Rat insulin <0.000004% Mouse insulin <0.0003% Mouse C-peptide <0.00007% No interference by lipaemic, icteric or haemolysed samples

Description	High Range Porcine Insulin ELISA	Feline Insulin ELISA
Code No.	10-1223-01	10-1233-01
No. of tests	96	96
Measured antigen	Porcine Insulin	Feline Insulin
Standards	c. 0 - 75 g/l (0 + 5 standards)	0, 5, 35, 100, 350, 700 ng/l
Incubation (mins)	60 + 15	120+30
Sample/sample volume	serum/plasma 10ul	serum/plasma 10ul
Sensitivity	0.313ug/l	5ng/l
Precision intra/inter cv%	<2.3%/<5%	<4.8%/<8.9%
Hook	11500 ug/l	27600 ug/l
Cross-reactions	Porcine C-peptide <0.001% Porcine Proinsulin <0.2% Human insulin 28% Human Proinsulin <0.1% Human C-peptide <0.01% Aspart (NovoRapid) 0.7% Detemir (Levemir) <0.0000002% Glargin (Lantus) 5.4% Lispro (Humalog) <0.0000006% No interference by lipaemic, icteric or haemolysed samples	Aspart (NovoRapid®) 5.9% Detemir (Levemir®) <0.008% Glargin (Lantus®) 8.4% Lispro (Humalog®) <0.00000002% Glulisine (Apidra®) <0.0000007% Letsulin® , Caninsulin® 57.4% No interference by lipaemic, icteric or haemolysed samples

Description	Canine Insulin ELISA	Equine Insulin ELISA
Code No.	10-1203-01	10-1205-01
No. of tests	96	96
Measured antigen	Canine Insulin	Equine Insulin
Standards ug/l	0, 0.02, 0.05, 0.15, 0.50, 1.50	0, 0.02, 0.05, 0.15, 0.50, 1.50
Calibration	in-house porcine insulin reference	in-house porcine insulin reference
Incubation (mins)	120 + 15	120 + 15
Sample/sample volume	serum/plasma 25ul	serum/plasma 25ul
Sensitivity	≤0.01 ug/l	≤0.01 ug/l
Precision intra/inter cv%	<4.5%/<6.2%	<3.4%/<4.3%
Hook	>1000ug/l	>1000ug/l
Cross-reactions	porcine insulin 100% porcine C-peptide <0.001% porcine proinsulin <0.20% human insulin 28% human C-peptide <0.01% human proinsulin <0.1% NovoRapid 0.7% Levemir <0.0000002% Lantus 5.4% Humalog <0.0000006% No interference by lipaemic, icteric or haemolysed samples	porcine insulin 100% porcine C-peptide <0.001% porcine proinsulin <0.20% human insulin 28% human C-peptide <0.01% human proinsulin <0.1% NovoRapid 0.7% Levemir <0.0000002% Lantus 5.4% Humalog <0.0000006% No interference by lipaemic, icteric or haemolysed samples

Description	Porcine C-peptide ELISA	Rat Glicentin ELISA
Code No.	10-1156-01	10-1275-01
No. of tests	96	96
Measured antigen	Porcine C-peptide	Rat Glicentin
Standards pmol/L	c. 0—1500 (0 + 5 standards)	5—500 pmol/l
Incubation (mins)	120 + 60 + 15	overnight + 15
Sample/sample volume	serum/plasma/cell culture 10ul	Serum/plasma 10ul
Sensitivity	10 pmol/L	5 pmol/L
Precision intra/inter cv%	<3.7%/<3.8%	Total 7—14%
Hook	>30000 pmol/L	>11,000 pmol/l
Cross-reactions	Porcine insulin <0.05% Porcine proinsulin <0.02% Human C-peptide <0.003% Human proinsulin <0.01% Macaque C-peptide <0.006% Mouse C-peptide <0.007% Mouse insulin <0.13% Mouse proinsulin <0.002% Rat C-peptide 0.08% Rat insulin <0.002% Rat proinsulin <0.002%	Oxyntomodulin ND Mini-Glucagon ND GLP-1 ND GLP-2 ND Glucagon ND Human Glicentin <1.7% Mouse Glicentin 5.2%

上一條Mercodia人類糖尿病產(chǎn)品
下一條alichem 17894-99-4說明書